These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 8276294

  • 1. Assessment of primary and metastatic ovarian cancer by positron emission tomography (PET) using 2-[18F]deoxyglucose (2-[18F]FDG).
    Hubner KF, McDonald TW, Niethammer JG, Smith GT, Gould HR, Buonocore E.
    Gynecol Oncol; 1993 Nov; 51(2):197-204. PubMed ID: 8276294
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma.
    Gritters LS, Francis IR, Zasadny KR, Wahl RL.
    J Nucl Med; 1993 Sep; 34(9):1420-7. PubMed ID: 8355058
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology.
    Castellucci P, Perrone AM, Picchio M, Ghi T, Farsad M, Nanni C, Messa C, Meriggiola MC, Pelusi G, Al-Nahhas A, Rubello D, Fazio F, Fanti S.
    Nucl Med Commun; 2007 Aug; 28(8):589-95. PubMed ID: 17625380
    [Abstract] [Full Text] [Related]

  • 11. Whole-body PET with (fluorine-18)-2-deoxyglucose for detecting recurrent ovarian carcinoma. Initial report.
    Yuan CC, Liu RS, Wang PH, Ng HT, Yeh SH.
    J Reprod Med; 1999 Sep; 44(9):775-8. PubMed ID: 10509300
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Usefulness of whole body positron emission tomography (PET) with 18F-fluoro-2-deoxyglucose (FDG) to detect recurrent ovarian cancer based on asymptomatically elevated serum levels of tumor marker.
    Chang WC, Hung YC, Kao CH, Yen RF, Shen YY, Lin CC.
    Neoplasma; 2002 Sep; 49(5):329-33. PubMed ID: 12458332
    [Abstract] [Full Text] [Related]

  • 15. Krukenberg tumor and lung metastases from colon carcinoma diagnosed with F-18 FDG PET.
    Bohdiewicz PJ, Juni JE, Ball D, Dworkin H.
    Clin Nucl Med; 1995 May; 20(5):419-20. PubMed ID: 7628145
    [Abstract] [Full Text] [Related]

  • 16. Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET.
    Kahn D, Follett KA, Bushnell DL, Nathan MA, Piper JG, Madsen M, Kirchner PT.
    AJR Am J Roentgenol; 1994 Dec; 163(6):1459-65. PubMed ID: 7992747
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of pancreatic tumors with positron emission tomography and F-18 fluorodeoxyglucose: comparison with CT and US.
    Inokuma T, Tamaki N, Torizuka T, Magata Y, Fujii M, Yonekura Y, Kajiyama T, Ohshio G, Imamura M, Konishi J.
    Radiology; 1995 May; 195(2):345-52. PubMed ID: 7724751
    [Abstract] [Full Text] [Related]

  • 19. Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT.
    Newman JS, Francis IR, Kaminski MS, Wahl RL.
    Radiology; 1994 Jan; 190(1):111-6. PubMed ID: 8259386
    [Abstract] [Full Text] [Related]

  • 20. Fluorine-18-FDG PET in Paget's disease of bone.
    Cook GJ, Maisey MN, Fogelman I.
    J Nucl Med; 1997 Sep; 38(9):1495-7. PubMed ID: 9293817
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.